Literature DB >> 17407517

Laparoscopic distal ureterectomy and anastomosis for management of low-risk upper urinary tract transitional cell carcinoma: preliminary results.

Morgan Rouprêt1, Justin D Harmon, Kristin M Sanderson, Eric Barret, Xavier Cathelineau, Guy Vallancien, François Rozet.   

Abstract

OBJECTIVE: To determine the surgical feasibility and early oncological outcomes of laparoscopic distal ureterectomy in patients with low-grade upper urinary tract transitional cell carcinoma (UUT-TCC). PATIENTS AND METHODS: We retrospectively reviewed patients treated laparoscopically with conservative management for a UUT-TCC between 2001 and 2005. We collected data on gender, age, mode of diagnosis, smoking, history of bladder cancer, complications, tumour site, size, stage, grade, hospital stay, recurrence and progression.
RESULTS: Data were analysed for six patients with a mean (range) age of 68.5 (54-76) years. Four patients had a diagnostic ureteroscopy with biopsy. The operative duration was 173.3 (120-240) min, the estimated blood loss was 75 (50-200) mL and the length of ureteric resection was 5.23 cm. Two patients required a psoas hitch. JJ stents were maintained for 25.8 (15-30) days. The hospital stay was 6 (5-8) days. There were minor complications in three patients after surgery. The follow-up was 32 (17-46) months. The tumour size was 1.7 (0.8-2.6) cm. There were low-grade tumours in four patients and pTa in five. All patients are alive and free of disease; there were no anastomotic strictures. Two patients developed a recurrence, one in the ipsilateral renal pelvis and one in the bladder.
CONCLUSION: Laparoscopic distal ureterectomy with direct re-implantation is technically feasible for low-risk UUT-TCC (i.e. low-grade, noninvasive), in the properly selected patient. Early oncological outcomes are promising but strict surveillance protocols must be followed.

Entities:  

Mesh:

Year:  2007        PMID: 17407517     DOI: 10.1111/j.1464-410X.2006.06688.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  8 in total

Review 1.  Nephron-sparing Management of Upper Tract Urothelial Carcinoma.

Authors:  Francesca Suriano; Tommaso Brancato
Journal:  Rev Urol       Date:  2014

Review 2.  Risk-adapted strategy for the kidney-sparing management of upper tract tumours.

Authors:  Thomas Seisen; Pierre Colin; Morgan Rouprêt
Journal:  Nat Rev Urol       Date:  2015-02-24       Impact factor: 14.432

Review 3.  [Endosopic organ-sparing treatment of urothelial tumors of the upper urinary tract: indications and results].

Authors:  M Hruza; C Stock; D Teber; J J Rassweiler
Journal:  Urologe A       Date:  2008-07       Impact factor: 0.639

Review 4.  Oncological risk of laparoscopic surgery in urothelial carcinomas.

Authors:  Morgan Rouprêt; Gordon Smyth; Jacques Irani; Laurent Guy; Jean-Louis Davin; Fabien Saint; Christian Pfister; Hervé Wallerand; François Rozet
Journal:  World J Urol       Date:  2008-11-20       Impact factor: 4.226

5.  Surgical management of upper tract urothelial carcinoma.

Authors:  Vincent G Bird; Prashanth Kanagarajah
Journal:  Indian J Urol       Date:  2011-01

6.  Laparoscopic ureteroneocystostomy: modification of current techniques.

Authors:  Jae Hyun Ahn; Ji-Yeon Han; Jong Kil Nam; Sung-Woo Park; Sang Don Lee; Moon Kee Chung
Journal:  Korean J Urol       Date:  2013-01-18

7.  Robot-assisted laparoscopic distal ureteral surgery.

Authors:  Megan O Schimpf; Joseph R Wagner
Journal:  JSLS       Date:  2009 Jan-Mar       Impact factor: 2.172

Review 8.  Nephron-sparing approaches in the management of upper tract urothelial carcinoma: indications and clinical outcomes.

Authors:  Young Hwii Ko
Journal:  Transl Cancer Res       Date:  2020-10       Impact factor: 1.241

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.